Frequency of actionable secondary findings in 7472 Korean genomes derived from the National Project of Bio Big Data pilot study
Open Access
- 20 September 2023
- journal article
- research article
- Published by Springer Nature in Human Genetics
- Vol. 142 (11) , 1561-1569
Abstract
Exome and genome sequencing (ES/GS) in genetic medicine and research leads to discovering genomic secondary findings (SFs) unrelated to the purpose of the primary test. There is a lack of agreement to return the SF results for individuals undergoing the test. The aim of this study is to investigate the frequency of actionable secondary findings using GS data obtained from the rare disease study and the Korean Genome and Epidemiology Study (KoGES) in the National Project of Bio Big Data pilot study. Pathogenic (P) or likely pathogenic (LP) variants of 78 SF genes recommended by the American College of Medical Genetics and Genomics (ACMG) were screened in the rare disease study and KoGES. The pathogenicity of SF gene variants was determined according to the ACMG interpretation. The overall SF rate was 3.75% for 280 individuals with 298 P/LP variants of 41 ACMG SF genes which were identified among 7472 study participants. The frequencies of genes associated with cardiovascular, cancer, and miscellaneous phenotypes were 2.17%, 1.22%, and 0.58%, respectively. The most frequent SF gene was TTN followed by BRCA2. The frequency of actionable SFs among participants with rare disease and general population participants in the Korean population presented here will assist in reporting results of medically actionable SFs in genomic medicine.Keywords
Funding Information
- Korea National Institute of Health (2022-NI-060-01, 2022-NI-060-01, 2022-NI-060-01, 2022-NI-060-01, 2022-NI-060-01)
This publication has 55 references indexed in Scilit:
- Overcalling secondary findingsGenetics in Medicine, 2016
- Ancient DNA and the rewriting of human history: be sparing with Occam’s razorGenome Biology, 2016
- Frequency and spectrum of actionable pathogenic secondary findings in 196 Korean exomesGenetics in Medicine, 2015
- Identification of Medically Actionable Secondary Findings in the 1000 GenomesPLOS ONE, 2015
- ClinGen — The Clinical Genome ResourceNew England Journal of Medicine, 2015
- Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular PathologyGenetics in Medicine, 2015
- The implications of familial incidental findings from exome sequencing: the NIH Undiagnosed Diseases Program experienceGenetics in Medicine, 2014
- ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencingGenetics in Medicine, 2013
- Whole-genome sequencing in health careEuropean Journal of Human Genetics, 2013
- ANNOVAR: functional annotation of genetic variants from high-throughput sequencing dataNucleic Acids Research, 2010